ARQT NASDAQ
Credit Risk of going bust: lower than 69% of companies Debt: 2.8% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.11 (down 99.7%), Arcutis Biotherapeutics, Inc. would be worth roughly what it owes.
Total debt $114.1M against a stock market value of $4.00B.
Distance to default 7.38 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $57.9M (short-term plus half of long-term), stock volatility 56.8%; Altman Z'' -2.01. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Westlake Village, CA 91361
US
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Welgus Howard G. | M-Exempt | 822 | $6.52 | 2026-10-15 |
| Welgus Howard G. | M-Exempt | 1,018 | $7.51 | 2026-10-15 |
| Welgus Howard G. | M-Exempt | 2,254 | $8.63 | 2026-10-15 |
| Welgus Howard G. | S-Sale | 4,728 | $26.93 | 2026-10-15 |
| Welgus Howard G. | M-Exempt | 822 | $6.52 | 2026-10-15 |